Abstract
Abstract Purpose of Review Dimethyl Sulfoxide (DMSO) remains an option for the treatment of bladder pain syndrome/interstitial cystitis (BPS/IC) in select patients. This review will discuss the mechanism of action and the role of intravesical DMSO cocktail therapy, as well as outcomes and adverse events for this therapy. Recent Findings Several, but not all historical studies have demonstrated some efficacy for DMSO in the treatment of BPS/IC symptoms including pain and lower urinary tract symptoms such as urgency and frequency. Although DMSO appears superior to placebo, there remain few well-done studies demonstrating support for DMSO use versus other intravesical or alternative BPS/IC treatments. AUA guidelines regarding the role of DMSO have been recently updated. Summary Despite a long history of utilization in the treatment of BPS/IC, the literature supporting its use is not particularly robust. Current AUA guidelines support DMSO as an option in selected patients with a modest level of evidence.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
